Source: Υπουργείο Υγείας (CY) Revision Year: 2014 Publisher: Medochemie Ltd, 1-10 Constantinopoleos Street, 3011 Limassol, Cyprus
Clarantin 100 mg hard capsules.
| Pharmaceutical Form |
|---|
|
Hard capsule. Brown and green hard gelatin capsule size “2” or brown and green hard gelatin capsule size “2” printed “Medochemie”. |
Naftidrofuryl oxalate.
Each capsule of Clarantin contains 100mg of Naftidrofuryl oxalate.
Excipient with known effect: carmoisine.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Naftidrofuryl |
Naftidrofuryl oxalate is a powerful vasodilator agent with an antagonist effect on 5-HT2 receptors of the smooth muscle cells. The vasodilator effect, which occurs in both the cerebral and peripheral circulation, is probably the main action. It is claimed that this action protects cells against the metabolic effects of ischaemia. |
| List of Excipients |
|---|
|
Polyvinylpyrolidone K25 Constituents of capsule shell: Gelatine |
The capsules are packed in PVC/Al blisters, PVDC/Al blisters or securitainers.
Cartons of 20, 60, 100, 500 and 1000 capsules are available. Securitainers of PVC of 100, 500 and 1 000 capsules are available.
Not all pack sizes may be marketed.
Medochemie Ltd, 1-10 Constantinopoleos Street, 3011 Limassol, Cyprus
20374
17/07/2008
| Drug | Countries | |
|---|---|---|
| CLARANTIN | Cyprus, Tunisia |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.